NYSE: UPHUphealth Inc Stock
$1.42-0.04 (-2.74%)
Updated Jun 6, 2023
UPH Price
$1.42
Fair Value Price
N/A
Market Cap
$23.83M
52 Week Low
$1.27
52 Week High
$9.50
P/E
-0.1x
P/B
0.23x
P/S
0.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$164.98M
Earnings
-$213.64M
Gross Margin
47%
Operating Margin
-117.81%
Profit Margin
-129.5%
Debt to Equity
2.3
Operating Cash Flow
-$23M
Beta
0.38
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
UPH Overview
GigCapital2, Inc. is a blank check company. The company is headquartered in Palo Alto, California. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses. The Company’s initial business combination is not limited to any business, industry or geographic location, and intends to identify, acquire and operate a business in the thermos mechanical treatment (TMT) industry. The firm is not engaged in any business operations and has not generated any revenue.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how UPH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
UPH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UPH is good value based on its book value relative to its share price (0.23x), compared to the US Health Information Services industry average (3.57x)
P/B vs Industry Valuation
UPH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more UPH due diligence checks available for Premium users.
Be the first to know about important UPH news, forecast changes, insider trades & much more!
UPH News
Valuation
UPH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.1x
Industry
5.29x
Market
53.54x
UPH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.23x
Industry
3.57x
UPH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
UPH's financial health
Profit margin
Revenue
$42.1M
Net Income
-$8.1M
Profit Margin
-19.2%
UPH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
UPH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$338.8M
Liabilities
$235.2M
Debt to equity
2.3
UPH's short-term liabilities ($69.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UPH's long-term liabilities ($165.83M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UPH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.0M
Investing
-$1.3M
Financing
$3.2M
UPH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
UPH vs Health Information Service Stocks
Uphealth Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.